시장조사 보고서 : 세계의 인간 혈장 제품 및 유도체 시장예측 2021년-2026년

■ 영문 제목 : Global Human Plasma Products and Derivatives Market Growth (Status and Outlook) 2021-2026
	■ 상품코드 : LPI-2201K00047 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 106 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료, 제약

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1명 열람용)	USD3,660 ⇒환산￦5,124,000	견적의뢰/주문/질문
Multi User (5명 열람용)	USD5,490 ⇒환산￦7,686,000	견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)	USD7,320 ⇒환산￦10,248,000	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

본 조사보고서는 인간 혈장 제품 및 유도체의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (응고 인자, 면역글로불린, 알부민, 기타)와 용도별 시장규모 (병원, 약국, 기타) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 인간 혈장 제품 및 유도체 시장 점유율
- 지역별 인간 혈장 제품 및 유도체 시장규모
- 주요지역의 종류별 시장규모 (응고 인자, 면역글로불린, 알부민, 기타)
- 주요지역의 용도별 시장규모 (병원, 약국, 기타)
- 미주의 인간 혈장 제품 및 유도체 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 인간 혈장 제품 및 유도체 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 인간 혈장 제품 및 유도체 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 인간 혈장 제품 및 유도체 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 인간 혈장 제품 및 유도체 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, RAAS, CBPO, Hualan Bio
- 조사의 결과/결론

■ 보고서 개요

According to this latest study, the 2021 growth of Human Plasma Products and Derivatives will have significant change from previous year. By the most conservative estimates of global Human Plasma Products and Derivatives market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Human Plasma Products and Derivatives market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Plasma Products and Derivatives market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Coagulation Factor
Immune Globulin
Albumin
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Hospital
Retail Pharmacy
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Plasma Products and Derivatives Market Size 2016-2026
2.1.2 Human Plasma Products and Derivatives Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Human Plasma Products and Derivatives Segment by Type
2.2.1 Coagulation Factor
2.2.2 Coagulation Factor
2.2.3 Albumin
2.2.4 Others
2.3 Human Plasma Products and Derivatives Market Size by Type
2.3.1 Global Human Plasma Products and Derivatives Market Size CAGR by Type
2.3.2 Global Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
2.4 Human Plasma Products and Derivatives Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Others
2.5 Human Plasma Products and Derivatives Market Size by Application
2.5.1 Global Human Plasma Products and Derivatives Market Size CAGR by Application
2.5.2 Global Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)

3 Human Plasma Products and Derivatives Market Size by Players
3.1 Human Plasma Products and Derivatives Market Size Market Share by Players
3.1.1 Global Human Plasma Products and Derivatives Revenue by Players (2019-2021E)
3.1.2 Global Human Plasma Products and Derivatives Revenue Market Share by Players (2019-2021E)
3.2 Global Human Plasma Products and Derivatives Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Human Plasma Products and Derivatives by Regions
4.1 Human Plasma Products and Derivatives Market Size by Regions (2016-2021)
4.2 Americas Human Plasma Products and Derivatives Market Size Growth (2016-2021)
4.3 APAC Human Plasma Products and Derivatives Market Size Growth (2016-2021)
4.4 Europe Human Plasma Products and Derivatives Market Size Growth (2016-2021)
4.5 Middle East & Africa Human Plasma Products and Derivatives Market Size Growth (2016-2021)

5 Americas
5.1 Americas Human Plasma Products and Derivatives Market Size by Country (2016-2021)
5.2 Americas Human Plasma Products and Derivatives Market Size by Type (2016-2021)
5.3 Americas Human Plasma Products and Derivatives Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Human Plasma Products and Derivatives Market Size by Region (2016-2021)
6.2 APAC Human Plasma Products and Derivatives Market Size by Type (2016-2021)
6.3 APAC Human Plasma Products and Derivatives Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Human Plasma Products and Derivatives by Country (2016-2021)
7.2 Europe Human Plasma Products and Derivatives Market Size by Type (2016-2021)
7.3 Europe Human Plasma Products and Derivatives Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Human Plasma Products and Derivatives by Region (2016-2021)
8.2 Middle East & Africa Human Plasma Products and Derivatives Market Size by Type (2016-2021)
8.3 Middle East & Africa Human Plasma Products and Derivatives Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Human Plasma Products and Derivatives Market Forecast
10.1 Global Human Plasma Products and Derivatives Forecast by Regions (2021-2026)
10.1.1 Global Human Plasma Products and Derivatives Forecast by Regions (2021-2026)
10.1.2 Americas Human Plasma Products and Derivatives Forecast
10.1.3 APAC Human Plasma Products and Derivatives Forecast
10.1.4 Europe Human Plasma Products and Derivatives Forecast
10.1.5 Middle East & Africa Human Plasma Products and Derivatives Forecast
10.2 Americas Human Plasma Products and Derivatives Forecast by Countries (2021-2026)
10.2.1 United States Human Plasma Products and Derivatives Market Forecast
10.2.2 Canada Human Plasma Products and Derivatives Market Forecast
10.2.3 Mexico Human Plasma Products and Derivatives Market Forecast
10.2.4 Brazil Human Plasma Products and Derivatives Market Forecast
10.3 APAC Human Plasma Products and Derivatives Forecast by Region (2021-2026)
10.3.1 China Human Plasma Products and Derivatives Market Forecast
10.3.2 Japan Human Plasma Products and Derivatives Market Forecast
10.3.3 Korea Human Plasma Products and Derivatives Market Forecast
10.3.4 Southeast Asia Human Plasma Products and Derivatives Market Forecast
10.3.5 India Human Plasma Products and Derivatives Market Forecast
10.3.6 Australia Human Plasma Products and Derivatives Market Forecast
10.4 Europe Human Plasma Products and Derivatives Forecast by Country (2021-2026)
10.4.1 Germany Human Plasma Products and Derivatives Market Forecast
10.4.2 France Human Plasma Products and Derivatives Market Forecast
10.4.3 UK Human Plasma Products and Derivatives Market Forecast
10.4.4 Italy Human Plasma Products and Derivatives Market Forecast
10.4.5 Russia Human Plasma Products and Derivatives Market Forecast
10.5 Middle East & Africa Human Plasma Products and Derivatives Forecast by Region (2021-2026)
10.5.1 Egypt Human Plasma Products and Derivatives Market Forecast
10.5.2 South Africa Human Plasma Products and Derivatives Market Forecast
10.5.3 Israel Human Plasma Products and Derivatives Market Forecast
10.5.4 Turkey Human Plasma Products and Derivatives Market Forecast
10.5.5 GCC Countries Human Plasma Products and Derivatives Market Forecast
10.6 Global Human Plasma Products and Derivatives Forecast by Type (2021-2026)
10.7 Global Human Plasma Products and Derivatives Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Human Plasma Products and Derivatives Product Offered
11.1.3 Takeda Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Takeda Main Business Overview
11.1.5 Takeda Latest Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Human Plasma Products and Derivatives Product Offered
11.2.3 CSL Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 CSL Main Business Overview
11.2.5 CSL Latest Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Human Plasma Products and Derivatives Product Offered
11.3.3 Grifols Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Grifols Main Business Overview
11.3.5 Grifols Latest Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Human Plasma Products and Derivatives Product Offered
11.4.3 Octapharma Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Octapharma Main Business Overview
11.4.5 Octapharma Latest Developments
11.5 Kedrion
11.5.1 Kedrion Company Information
11.5.2 Kedrion Human Plasma Products and Derivatives Product Offered
11.5.3 Kedrion Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Kedrion Main Business Overview
11.5.5 Kedrion Latest Developments
11.6 LFB Group
11.6.1 LFB Group Company Information
11.6.2 LFB Group Human Plasma Products and Derivatives Product Offered
11.6.3 LFB Group Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 LFB Group Main Business Overview
11.6.5 LFB Group Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Human Plasma Products and Derivatives Product Offered
11.7.3 Biotest Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 BPL
11.8.1 BPL Company Information
11.8.2 BPL Human Plasma Products and Derivatives Product Offered
11.8.3 BPL Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 BPL Main Business Overview
11.8.5 BPL Latest Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Human Plasma Products and Derivatives Product Offered
11.9.3 RAAS Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 RAAS Main Business Overview
11.9.5 RAAS Latest Developments
11.10 CBPO
11.10.1 CBPO Company Information
11.10.2 CBPO Human Plasma Products and Derivatives Product Offered
11.10.3 CBPO Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 CBPO Main Business Overview
11.10.5 CBPO Latest Developments
11. Hualan Bio
11.11.1 Hualan Bio Company Information
11.11.2 Hualan Bio Human Plasma Products and Derivatives Product Offered
11.11.3 Hualan Bio Human Plasma Products and Derivatives Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Hualan Bio Main Business Overview
11.11.5 Hualan Bio Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Human Plasma Products and Derivatives Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Coagulation Factor
Table 3. Major Players of Immune Globulin
Table 4. Major Players of Albumin
Table 5. Major Players of Others
Table 6. Human Plasma Products and Derivatives Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Human Plasma Products and Derivatives Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
Table 9. Human Plasma Products and Derivatives Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Human Plasma Products and Derivatives Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)
Table 12. Global Human Plasma Products and Derivatives Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Human Plasma Products and Derivatives Revenue Market Share by Players (2019-2021E)
Table 14. Human Plasma Products and Derivatives Key Players Head office and Products Offered
Table 15. Human Plasma Products and Derivatives Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Plasma Products and Derivatives Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Human Plasma Products and Derivatives Market Size Market Share by Regions 2016-2021
Table 20. Americas Human Plasma Products and Derivatives Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Human Plasma Products and Derivatives Market Size Market Share by Country (2016-2021)
Table 22. Americas Human Plasma Products and Derivatives Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
Table 24. Americas Human Plasma Products and Derivatives Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)
Table 26. APAC Human Plasma Products and Derivatives Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Human Plasma Products and Derivatives Market Size Market Share by Region (2016-2021)
Table 28. APAC Human Plasma Products and Derivatives Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
Table 30. APAC Human Plasma Products and Derivatives Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)
Table 32. Europe Human Plasma Products and Derivatives Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Human Plasma Products and Derivatives Market Size Market Share by Country (2016-2021)
Table 34. Europe Human Plasma Products and Derivatives Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
Table 36. Europe Human Plasma Products and Derivatives Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Human Plasma Products and Derivatives Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Human Plasma Products and Derivatives Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Human Plasma Products and Derivatives Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Human Plasma Products and Derivatives
Table 45. Key Application and Potential Industries of Human Plasma Products and Derivatives
Table 46. Key Challenges of Human Plasma Products and Derivatives
Table 47. Key Trends of Human Plasma Products and Derivatives
Table 48. Global Human Plasma Products and Derivatives Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Human Plasma Products and Derivatives Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Human Plasma Products and Derivatives Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Human Plasma Products and Derivatives Market Size Market Share Forecast by Application (2021-2026)
Table 54. Takeda Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 55. Takeda Human Plasma Products and Derivatives Product Offered
Table 56. Takeda Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. Takeda Main Business
Table 58. Takeda Latest Developments
Table 59. CSL Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 60. CSL Human Plasma Products and Derivatives Product Offered
Table 61. CSL Main Business
Table 62. CSL Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. CSL Latest Developments
Table 64. Grifols Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 65. Grifols Human Plasma Products and Derivatives Product Offered
Table 66. Grifols Main Business
Table 67. Grifols Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Grifols Latest Developments
Table 69. Octapharma Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 70. Octapharma Human Plasma Products and Derivatives Product Offered
Table 71. Octapharma Main Business
Table 72. Octapharma Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Octapharma Latest Developments
Table 74. Kedrion Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 75. Kedrion Human Plasma Products and Derivatives Product Offered
Table 76. Kedrion Main Business
Table 77. Kedrion Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Kedrion Latest Developments
Table 79. LFB Group Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 80. LFB Group Human Plasma Products and Derivatives Product Offered
Table 81. LFB Group Main Business
Table 82. LFB Group Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. LFB Group Latest Developments
Table 84. Biotest Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 85. Biotest Human Plasma Products and Derivatives Product Offered
Table 86. Biotest Main Business
Table 87. Biotest Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Biotest Latest Developments
Table 89. BPL Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 90. BPL Human Plasma Products and Derivatives Product Offered
Table 91. BPL Main Business
Table 92. BPL Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. BPL Latest Developments
Table 94. RAAS Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 95. RAAS Human Plasma Products and Derivatives Product Offered
Table 96. RAAS Main Business
Table 97. RAAS Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. RAAS Latest Developments
Table 99. CBPO Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 100. CBPO Human Plasma Products and Derivatives Product Offered
Table 101. CBPO Main Business
Table 102. CBPO Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. CBPO Latest Developments
Table 104. Hualan Bio Details, Company Type, Human Plasma Products and Derivatives Area Served and Its Competitors
Table 105. Hualan Bio Human Plasma Products and Derivatives Product Offered
Table 106. Hualan Bio Human Plasma Products and Derivatives Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Hualan Bio Main Business
Table 108. Hualan Bio Latest Developments
List of Figures
Figure 1. Human Plasma Products and Derivatives Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Plasma Products and Derivatives Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Human Plasma Products and Derivatives Market Size Market Share by Type in 2020
Figure 7. Human Plasma Products and Derivatives in Hospital
Figure 8. Global Human Plasma Products and Derivatives Market: Hospital (2016-2021) & ($ Millions)
Figure 9. Human Plasma Products and Derivatives in Retail Pharmacy
Figure 10. Global Human Plasma Products and Derivatives Market: Retail Pharmacy (2016-2021) & ($ Millions)
Figure 11. Human Plasma Products and Derivatives in Others
Figure 12. Global Human Plasma Products and Derivatives Market: Others (2016-2021) & ($ Millions)
Figure 13. Global Human Plasma Products and Derivatives Market Size Market Share by Application in 2020
Figure 14. Global Human Plasma Products and Derivatives Revenue Market Share by Player in 2020
Figure 15. Global Human Plasma Products and Derivatives Market Size Market Share by Regions (2016-2021)
Figure 16. Americas Human Plasma Products and Derivatives Market Size 2016-2021 ($ Millions)
Figure 17. APAC Human Plasma Products and Derivatives Market Size 2016-2021 ($ Millions)
Figure 18. Europe Human Plasma Products and Derivatives Market Size 2016-2021 ($ Millions)
Figure 19. Middle East & Africa Human Plasma Products and Derivatives Market Size 2016-2021 ($ Millions)
Figure 20. Americas Human Plasma Products and Derivatives Market Size Market Share by Country in 2020
Figure 21. Americas Human Plasma Products and Derivatives Market Size Market Share by Type in 2020
Figure 22. Americas Human Plasma Products and Derivatives Market Size Market Share by Application in 2020
Figure 23. United States Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 24. Canada Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 25. Mexico Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 26. APAC Human Plasma Products and Derivatives Market Size Market Share by Regions in 2020
Figure 27. APAC Human Plasma Products and Derivatives Market Size Market Share by Type in 2020
Figure 28. APAC Human Plasma Products and Derivatives Market Size Market Share by Application in 2020
Figure 29. China Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 30. Japan Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 31. Korea Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 32. Southeast Asia Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 33. India Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 34. Australia Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 35. Europe Human Plasma Products and Derivatives Market Size Market Share by Country in 2020
Figure 36. Europe Human Plasma Products and Derivatives Market Size Market Share by Type in 2020
Figure 37. Europe Human Plasma Products and Derivatives Market Size Market Share by Application in 2020
Figure 38. Germany Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 39. France Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 40. UK Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 41. Italy Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 42. Russia Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 43. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Region in 2020
Figure 44. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Type in 2020
Figure 45. Middle East & Africa Human Plasma Products and Derivatives Market Size Market Share by Application in 2020
Figure 46. Egypt Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 47. South Africa Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 48. Israel Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 49. Turkey Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 50. GCC Country Human Plasma Products and Derivatives Market Size Growth 2016-2021 ($ Millions)
Figure 51. Americas Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 52. APAC Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 53. Europe Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 54. Middle East & Africa Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 55. United States Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 56. Canada Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 57. Mexico Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 58. Brazil Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 59. China Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 60. Japan Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 61. Korea Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 62. Southeast Asia Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 63. India Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 64. Australia Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 65. Germany Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 66. France Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 67. UK Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 68. Italy Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 69. Russia Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 70. Spain Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 71. Egypt Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 72. South Africa Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 73. Israel Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 74. Turkey Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)
Figure 75. GCC Country Human Plasma Products and Derivatives Market Size 2021-2026 ($ Millions)

※본 조사보고서 [세계의 인간 혈장 제품 및 유도체 시장예측 2021년-2026년] (코드 : LPI-2201K00047) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 인간 혈장 제품 및 유도체 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

세계의 재조합 인간 인터페론 α1b 시장예측 2021년-2026년
LPI-2201K02160 / LP Information / 2021년 12월 / 본 조사보고서는 재조합 인간 인터페론 α1b의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Recombinant Human Interferon α1b will have significant change from previous year. By the most conservative estimates of global Recombinant Human Interferon α1b market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...

세계의 플라즈마 수집 시장예측 2021년-2026년
LPI-2201K02147 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 수집의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Collection will have significant change from previous year. By the most conservative estimates of global Plasma Collection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 분획용 플라즈마 시장예측 2021년-2026년
LPI-2201K02148 / LP Information / 2021년 12월 / 본 조사보고서는 분획용 플라즈마의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma for Fractionation will have significant change from previous year. By the most conservative estimates of global Plasma for Fractionation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 플라즈마 처리 시장예측 2021년-2026년
LPI-2201K02149 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 처리의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Processing will have significant change from previous year. By the most conservative estimates of global Plasma Processing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 플라즈마 유래 제품 시장예측 2021년-2026년
LPI-2201K02151 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 유래 제품의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Plasma-derived Product will have significant change from previous year. By the most conservative estimates of global Plasma-derived Product market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...

세계의 플라즈마 요법 시장예측 2021년-2026년
LPI-2201K02280 / LP Information / 2021년 12월 / 본 조사보고서는 플라즈마 요법의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Plasma Therapy will have significant change from previous year. By the most conservative estimates of global Plasma Therapy market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 239.8 million in 2020. Over...

세계의 인간 DNA 정량화 시장예측 2021년-2026년
LPI-2201K00135 / LP Information / 2021년 12월 / 본 조사보고서는 인간 DNA 정량화의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Human DNA Quantification will have significant change from previous year. By the most conservative estimates of global Human DNA Quantification market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...

세계의 인체 마이크로바이옴 시장예측 2021년-2026년
LPI-2201K00136 / LP Information / 2021년 12월 / 본 조사보고서는 인체 마이크로바이옴의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Human Microbiome will have significant change from previous year. By the most conservative estimates of global Human Microbiome market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 309.3 million in 2020. Over...

세계의 인간용 호메오파시 약물 시장예측 2021년-2026년
LPI-2201K00045 / LP Information / 2021년 12월 / 본 조사보고서는 인간용 호메오파시 약물의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Human Homeopathic Medicines will have significant change from previous year. By the most conservative estimates of global Human Homeopathic Medicines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...